Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 4/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.33 |
| ▸ | KDM4A | O75164 | 2/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2848935 | 0.83 | ALDH1A1 (0.40) | ALDH1A1KDM4EHPGDMAPTMEN1 | |
| SCHEMBL11739099 | 0.82 | NPSR1 (0.40) | ALDH1A1KDM4EHPGDMAPTMEN1 | |
| SCHEMBL11822220 | 0.82 | NPSR1 (0.40) | ALDH1A1KDM4EHPGDMAPTMEN1 | |
| SCHEMBL9007459 | 0.80 | ALDH1A1 (0.55) | ALDH1A1KDM4EHPGDMAPTMEN1 | |
| SCHEMBL9334266 | 0.79 | ALDH1A1 (0.39) | ALDH1A1KDM4EHPGDMAPTMEN1 | |
| SCHEMBL2672871 | 0.78 | PDE5A (0.45) | MEN1KMT2AGAALMNA | |
| SCHEMBL1426485 | 0.77 | LMNA (0.41) | ALDH1A1KDM4EHPGDMAPTMEN1 | |
| SCHEMBL20607282 | 0.75 | SMN1; SMN2 (0.41) | ALDH1A1KDM4EHPGDMAPTMEN1 | |
| SCHEMBL6327634 | 0.74 | PTGS1 (0.42) | ALDH1A1KDM4EHPGDMAPTMEN1 | |
| SCHEMBL2673247 | 0.72 | KDM4C (0.50) | ALDH1A1KDM4EMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3746489-A1 | PHOTOLABILE BARBITURATE COMPOUNDS | 3M Innovative Properties Company (US) | 2020-12-09 | — | — | EP | claimed |
| CN-111630072-A | Photolabile barbiturate compound | 3M创新有限公司 | 2020-09-04 | — | — | CN | claimed |
| WO-2019152187-A1 | PHOTOLABILE BARBITURATE COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-08-08 | — | — | WO | claimed |
| US-8853297-B2 | Method and means for infiltrating enamel lesions | CHARITE UNIVERSITATSMEDIZIN BERLIN (DE) | 2014-10-07 | — | — | US | claimed |
| US-20090304622-A1 | METHOD AND MEANS FOR INFILTRATING ENAMEL LESIONS | CHARITE-UNIVERSITATSMEDIZIN BERLIN (DE) | 2009-12-10 | — | — | US | claimed |
| EP-2023884-A1 | METHOD AND MEANS FOR INFILTRATING ENAMEL LESIONS | Ernst Mühlbauer GmbH & Co.KG (DE) | 2009-02-18 | — | — | EP | claimed |
| WO-2007131725-A1 | METHOD AND MEANS FOR INFILTRATING ENAMEL LESIONS | CHARITE-UNIVERSITÄTSMEDIZIN BERLIN (DE) | 2007-11-22 | — | — | WO | claimed |
| CN-116635452-B | Free radically polymerizable crosslinking agent, curable composition, and adhesive therefrom | 3M INNOVATIVE PROPERTIES CO. (US) | 2026-05-26 | — | — | CN | disclosed |
| US-12600885-B2 | Composition including monomer with a carboxylic acid group, monomer with a hydroxyl group, an alkyl monomer, and crosslinker and related article and method | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-04-14 | — | — | US | disclosed |
| US-12398301-B2 | Adhesives comprising cyclic imide addition-fragmentation and adhesion agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-08-26 | — | — | US | disclosed |
| US-12378340-B2 | Crosslinkers and curable compositions including the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-08-05 | — | — | US | disclosed |
| EP-4448672-B1 | CURABLE PRECURSOR OF AN ADHESIVE COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-05-28 | — | — | EP | disclosed |
| US-20250101278-A1 | CURABLE PRECURSOR OF AN ADHESIVE COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY | 2025-03-27 | — | — | US | disclosed |
| US-6852775-B1 | Polymerizable dental compositions | 3M ESPE AG (DE) | 2005-02-08 | — | — | US | disclosed |
| US-20040254261-A1 | Dental composition | GC CORPORATION (JP) | 2004-12-16 | — | — | US | disclosed |
| EP-1462079-A1 | Dental composition | GC Corporation (JP) | 2004-09-29 | — | — | EP | disclosed |
| US-20030158288-A1 | Two-component dental materials having a low setting temperature | 3M DEUTSCHLAND GMBH (DE) | 2003-08-21 | — | — | US | disclosed |
| US-6288138-B1 | Dental adhesive kit | SUN MEDICAL CO., LTD. (JP) | 2001-09-11 | — | — | US | disclosed |
| EP-0923924-A2 | Dental adhesive kit | SUN MEDICAL CO., LTD. (JP) | 1999-06-23 | — | — | EP | disclosed |
| US-4382983-A | PARTIALLY HYDROLYZED SILOXANE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600885-B2 | Composition including monomer with a carboxylic acid group, monomer with a hydroxyl group, an alkyl monomer, and crosslinker and related article and method | RAD51, HACL2, COL2A1 | ALDH1A1 577/4885KDM4E 3173/4885HPGD 1508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.